Studies have shown that AGAP2-AS1 is associated with the development of various cancers, including gastric cancer [2], non-small cell lung cancer (NSCLC) [3], breast cancer [4], pleomorphic glioblastoma [5], ovarian cancer [6], pancreatic cancer [7], and hepatocellular carcinoma (HCC) [8]. This evidence concerns the gene AGAP2 and hepatocellular carcinoma.